Nodexus Inc. (www.nodexus.com) is a biotechnology company that commercializes tools to accelerate biological workflows and make them universally accessible. Nodexus recently closed a $30M Series A financing round in order to advance manufacturing and commercialization of its flagship NX One platform and is backed by leading life science venture capital firms (RA Capital and Section 32). The NX One leverages microfluidics to enable efficient, easy-to-use, and affordable cell isolation for the quickest growing sectors of biotechnology. Learn more at http://www.nodexus.com
